405267-73-4

Usage

Uses

Used in Pharmaceutical Research:
(4-Amino-3-iodo-phenyl)-acetic acid ethyl ester is used as a building block for the synthesis of biologically active molecules, including potential drug candidates. Its chemical structure and properties make it suitable for further modification to create new compounds with desired pharmacological properties.
Used in Chemical Research:
In the field of chemical research, (4-Amino-3-iodo-phenyl)-acetic acid ethyl ester is used as a starting material for the synthesis of various organic compounds. Its unique structure allows for the development of new compounds with potential applications in different industries.
Used in Agrochemicals:
(4-Amino-3-iodo-phenyl)-acetic acid ethyl ester is also used as a building block for the synthesis of agrochemicals, such as pesticides and herbicides. Its potential to be modified and derivatized makes it a valuable compound in the development of new and effective agrochemical products.
Overall, (4-Amino-3-iodo-phenyl)-acetic acid ethyl ester is a versatile compound with potential applications in various research and development fields, including pharmaceuticals, chemical research, and agrochemicals. Its unique structure and properties make it a valuable asset for the synthesis of new compounds with desired properties.

Upstream product

• 5438-70-0 ethyl (4-amino-3,5-dibromophenyl)acetate 

Downstream Products

• 133178-71-9 2-(4-amino-3-iodophenyl)acetic acid 
• 459449-11-7 2-(4-amino-3-iodophenyl)ethanol 
• 635680-22-7 6-bromo-2-ethyl-5-{[2-(3-methoxyphenyl)ethylcarbamoyl]methyl}-1H-indole-3-carboxylic acid ethyl ester 
• 405267-78-9 6-bromo-5-{[2-(3-methoxy-phenyl)-ethylcarbamoyl]-methyl}-2-methyl-1H-indole-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF

The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and G

METHODS OF PROMOTING BETA CELL PROLIFERATION

The present disclosure provides methods of promoting proliferation of a pancreatic cell. The methods are useful for the treatment of diabetes and other diseases characterized by impaired glucose tolerance.

THIENOPYRIMIDINE AND THIENOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF

The present disclosure provides compounds and methods for inhibiting the interaction of menin with its upstream or downstream signaling molecules including but not limited to MLL1, MLL2 and MLL-fusion oncoproteins. Compounds of the disclosure may be used

HETEROCYCLIC DERIVATIVES AS RORGAMMA MODULATORS

The present invention provides novel compounds of formula (I) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, fibrotic diseases, or cholestatic diseases.

ARYLACETIC ACIDS AND RELATED COMPOUNDS FOR TREATMENT OF ALZHEIMER’S DISEASE

Compounds of formula I are useful in treatment of diseases associated with the deposition of β-amyloid in the brain.

Analogs of M4 selective synthetic muscarinic receptor antagonists: Synthesis, binding and pharmacokinetic properties

Recently, highly selective M4 muscarinic receptor antagonists (e.g., PD 0320115) have been synthesized and pharmacologically characterized. One compound, PD 0298029 which was selected for in vivo testing, had low bioavailability (rat ～5%) and p

Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists

Disclosed are compounds of the Formula I and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, wherein R1 is hydrogen, lower alkyl, COOR7, (un)substituted aryl, (un)substituted heteroaryl, (un)substituted aryla